The effects of long-term extracurricular scientific research on the medical students: Insight from Jinan University Medical School

The advantages and long-term effects of extracurricular scientific research on undergraduate college students in lots of international locations have been intensively investigated, but it surely stays obscure for Chinese medical college students. In this examine, we investigated the end result of 60 medical college students who’ve participated in extracurricular scientific research at Jinan University Medical School over a interval of 7 years (2011-2018). The outcomes revealed that these college students have contributed to 31 biomedical science articles in respected educational journals, as first- or co-authors.

Furthermore, additionally they independently procured numerous funding based mostly on their research achievements, and smaller awards for achievements in conferences and competitions. Assessment of the grade level common rating of these college students revealed that conducting extracurricular scientific research didn’t have an effect on their routine medical examine and examination grades (P>0.05). The college students benefited from collaborating in extracurricular research, by buying the potential to assume scientifically and enhancing their communication abilities.

In addition, the medical college students had been motivated to enlist for postgraduate research in order that they might additional embark in scientific research. In sum, Chinese medical college students are succesful of collaborating in scientific research and make a big contribution to science. Linear regressions had been adjusted for gender, anticipated specialty alternative, parental schooling, dwelling standing, monetary insecurity, randomization group and baseline JSE-S.

This examine was performed between February and March 2019, in the Eastern area of Saudi Arabia, utilizing scientific pharmacy college students at the two universities that supply a pharmacy program there (King Faisal University and Imam Abdulrahman bin Faisal University). An digital questionnaire instrument was tailored to discover the intentions of and boundaries to hold out medical research amongst the college students.

 Descriptive statistics are introduced as frequencies and percentages. A χ2 check was used to discover any statistically vital distinction between the pupil demographics and the intentions and boundaries relating to medical research. P ≤ 0.05 was thought-about statistically vital. Our examine highlights that the intention amongst scientific pharmacy college students to hold out medical research was poor. Educational establishments are suggested to offer extra monetary and logistic assist to their medical researchers.

Knowledge and attitudes of U.S. medical college students relating to the care of Asian American sufferers: a cross-sectional survey examine

Asian Americans (AsAm) are a quickly rising inhabitants in the U.S. With this rising inhabitants, U.S. healthcare suppliers have to be outfitted to offer culturally competent look after AsAm sufferers. This challenge surveyed U.S. medical college students on their information of and attitudes in the direction of AsAm to evaluate predictors of readiness to look after AsAm sufferers.
This cross-sectional examine surveyed medical college students who had accomplished at the least one scientific rotation. The survey was distributed on-line to 9 medical faculties all through the U.S. The survey measured self-rated information of, consolation with, cultural competency (CC) in the direction of, and specific biases in the direction of AsAm sufferers. The first three domains had been analyzed in a multivariate regression mannequin together with sociodemographic traits and previous scientific, curricular, and social experiences with AsAm. Explicit bias questions had been reported descriptively.
 There had been 688 respondents. Asian race, AsAm-prevalent hometown, AsAm-related extracurricular actions, Asian language information, and having taken a inhabitants well being course predicted elevated AsAm information. Social interactions with AsAm elevated consolation with AsAm sufferers. Increasing 12 months in medical college, extra frequent publicity to AsAm sufferers on rotations, and prior journey to an Asian nation had been predictors of elevated CC towards AsAm.
Importantly, having accomplished a CC course was a big predictor in all domains. In phrases of specific bias, college students felt that AsAm sufferers had been extra compliant than Caucasian sufferers. Students additionally believed that Caucasian sufferers had been usually extra prone to obtain self-perceived “most popular” versus “acceptable” care, however that in their very own scientific experiences neither group acquired most popular care.
Experience with and publicity to AsAm previous to and through medical college and CC programs might improve medical pupil information, consolation, and CC with AsAm sufferers. Standardized and longitudinal CC coaching, elevated simulations with AsAm sufferers, numerous pupil recruitment, and assist for college kids to have interaction in AsAm-related actions and work together with AsAm might enhance CC of future physicians in the direction of AsAm sufferers and presumably different minority populations.
The effects of long-term extracurricular scientific research on the medical students: Insight from Jinan University Medical School

Personality traits are related to cognitive empathy in medical college students however not with its evolution and interventions to enhance it

Cognitive empathy would possibly lower throughout medical college. Factors related to its evolution stay poorly understood, in addition to whether or not such components might average the impact of an intervention to protect cognitive empathy. The intention was to discover the associations between character traits and each cognitive empathy at baseline and its adjustments at follow-up. The attainable impact of an intervention depended upon character traits was additionally examined.
The cohort consisted of fourth 12 months medical college students and the associations between character traits, utilizing the Short Big Five Inventory, and cognitive empathy adjustments at 3-month, utilizing the Jefferson Scale of Empathy-Student model (JSE-S), had been examined. A randomization in two teams (Balint teams versus no intervention) allowed analyzing whether or not the impact of the intervention depended upon character traits.

Angiotensin II Substrate Peptide

20-abx265623
  • EUR 467.00
  • EUR 759.00
  • EUR 342.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1] Angiotensin II Peptide

20-abx266586
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Angiotensin II (Ang II) Peptide (OVA)

20-abx651045
  • EUR 272.00
  • EUR 189.00
  • EUR 606.00
  • EUR 300.00
  • EUR 230.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Angiotensin II (4-8) Peptide

20-abx265182
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin II (3-8) Peptide

20-abx265183
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin II (1-4) Peptide

20-abx265185
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

[Asn1,Val5]-Angiotensin II Peptide

20-abx266003
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1,Gly8]-Angiotensin II Peptide

20-abx266581
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

[Sar1,Ala8]-Angiotensin II Peptide

20-abx266583
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

[Sar1,Ile4,8]-Angiotensin II Peptide

20-abx266584
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

[Sar1,Thr8]-Angiotensin II Peptide

20-abx266585
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Angiotensin II [Sar1 Ile8] Peptide

20-abx266588
  • EUR 718.00
  • EUR 328.00
  • EUR 467.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Angiotensin II

H-7714.0005 5.0mg
EUR 60
Description: Sum Formula: C50H71N13O12; CAS# [4474-91-3] net

Angiotensin II

H-1705.0025 25.0mg
EUR 176
Description: Sum Formula: C50H71N13O12; CAS# [4474-91-3] net

Angiotensin II

H-1705.0100 100.0mg
EUR 466
Description: Sum Formula: C50H71N13O12; CAS# [4474-91-3] net

Angiotensin II

A1042-10 10 mg
EUR 108
Description: Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu) is an octapeptide that is converted from Angiotensin I (AI) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung.

Angiotensin II

A1042-25 25 mg
EUR 131
Description: Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu) is an octapeptide that is converted from Angiotensin I (AI) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung.

Angiotensin II

A1042-250 250 mg
EUR 630
Description: Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu) is an octapeptide that is converted from Angiotensin I (AI) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung.

Angiotensin II

A1042-5 5 mg
EUR 84
Description: Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu) is an octapeptide that is converted from Angiotensin I (AI) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung.

Angiotensin II

4917-5MG
EUR 202

Positive control tissue section for each antibody; Based on availability INQUIRE

Control-Slides Set of 5
EUR 176

Angiotensin I / II (5-8) Peptide

20-abx265760
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin I / II (3-7) Peptide

20-abx265779
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin I / II (1-6) Peptide

20-abx265799
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1,Val5,Ala8]-Angiotensin II Peptide

20-abx266582
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Human Kinase Library II

HKIN-II 1 set
EUR 450

Human Drug Detoxication II

HDTX-II 1 set
EUR 645

Human Cytokine Primer Library II

HCA-II 1 set
EUR 450

Mouse Cytokine Primer Library II

MCA-II 1 set
EUR 450

Rat Cytokine Primer Library II

RCA-II 1 set
EUR 548

Angiotensin I / II (1-7) (Biotin) Peptide

20-abx266007
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

AT1A, Angiotensin II receptor, (225 237) Peptide

20-abx266391
  • EUR 523.00
  • EUR 871.00
  • EUR 384.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin II Type 1 Receptor Blocking Peptide

DF7592-BP 1mg
EUR 195

Human Deoxyribonuclease II (Dnase II) Control/blocking peptide # 1

DNASE21-P 100 ug
EUR 164

Mouse Deoxyribonuclease II (Dnase II) Control/blocking peptide # 2

DNASE22-P 100 ug
EUR 164

Human Colon Cancer Primer Library II

HCCP-II 1 set
EUR 548

Human DNA Repair Primer Library II

HDRL-II 1 set
EUR 548

Mouse DNA Repair Primer Library II

MDRL-II 1 set
EUR 645

Angiotensin II human

HY-13948 50mg
EUR 394

Angiotensin II Antipeptide

H-8160.0005 5.0mg
EUR 273
Description: Sum Formula: C42H62N10O12; CAS# [121379-63-3]

Angiotensin II Antipeptide

H-8160.0025 25.0mg
EUR 998
Description: Sum Formula: C42H62N10O12; CAS# [121379-63-3]

(Sar1)-Angiotensin II

H-1740.0025 25.0mg
EUR 273
Description: Sum Formula: C49H71N13O10; CAS# [51833-69-3]

(Sar1)-Angiotensin II

H-1740.0100 100.0mg
EUR 756
Description: Sum Formula: C49H71N13O10; CAS# [51833-69-3]

(Val5)-Angiotensin II

H-1750.0025 25.0mg
EUR 273
Description: Sum Formula: C49H69N13O12; CAS# [58-49-1]

(Val5)-Angiotensin II

H-1750.0100 100.0mg
EUR 756
Description: Sum Formula: C49H69N13O12; CAS# [58-49-1]

Angiotensin II Antipeptide

20-abx265974
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1] Angiotensin II

5-00293 24 x 5mg Ask for price

Angiotensin II Antipeptide

5-00686 4 x 5mg Ask for price

Angiotensin II human

5-00687 4 x 5mg Ask for price

Angiotensin II Substrate

5-00693 4 x 5mg Ask for price

Angiotensin II protein

30R-2769 5 mg
EUR 247
Description: Purified native Human Angiotensin II protein

Angiotensin II antibody

70-1089 100 ug
EUR 727
Description: Rabbit anti-human Angiotensin II antibody

Angiotensin II (Ang II) Antibody

20-abx130645
  • EUR 300.00
  • EUR 133.00
  • EUR 759.00
  • EUR 398.00
  • EUR 258.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Angiotensin II (Ang II) Antibody

20-abx131719
  • EUR 314.00
  • EUR 759.00
  • EUR 398.00
  • EUR 154.00
  • EUR 244.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-7 working days.

Angiotensin II (Ang II) Antibody

20-abx101258
  • EUR 300.00
  • EUR 133.00
  • EUR 759.00
  • EUR 398.00
  • EUR 258.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-15 working days.

Angiotensin II (Ang II) Antibody

abx021123-02mg 0.2 mg
EUR 1135
  • Shipped within 5-10 working days.

Human Interferon Type II Signaling Primer Library

HIFN-II 1 set
EUR 548

Human Cancer Driver Gene II Primer Library

HCDG-II 1 set
EUR 645

Angiotensin Peptide

20-abx265534
  • EUR 356.00
  • EUR 537.00
  • EUR 286.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1]-Angiotensin I / II (1-7) amide Peptide

20-abx266580
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Angiotensin II (Ang II) ELISA Kit

abx511338-96tests 96 tests
EUR 668
  • Shipped within 5-12 working days.

Mouse Hexokinase 2 (HXK-II) Control/blocking peptide

HXK23-P 100 ug
EUR 164

(Asn1,Val5)-Angiotensin II

H-6010.0025 25.0mg
EUR 321
Description: Sum Formula: C49H70N14O11; CAS# [53-73-6]

(Asn1,Val5)-Angiotensin II

H-6010.0100 100.0mg
EUR 902
Description: Sum Formula: C49H70N14O11; CAS# [53-73-6]

Angiotensin II Receptor Ligand

H-9395.0001 1.0mg
EUR 176
Description: Sum Formula: C52H69N13O11; CAS# [127060-75-7]

Angiotensin II Receptor Ligand

H-9395.0005 5.0mg
EUR 611
Description: Sum Formula: C52H69N13O11; CAS# [127060-75-7]

(Sar1,Gly8)-Angiotensin II

H-1725.0025 25.0mg
EUR 273
Description: Sum Formula: C42H65N13O10; CAS# [51887-62-8]

(Sar1,Gly8)-Angiotensin II

H-1725.0100 100.0mg
EUR 756
Description: Sum Formula: C42H65N13O10; CAS# [51887-62-8]

(Sar1,Ile8)-Angiotensin II

H-1730.0025 25.0mg
EUR 273
Description: Sum Formula: C46H73N13O10; CAS# [37827-06-8]

(Sar1,Ile8)-Angiotensin II

H-1730.0100 100.0mg
EUR 756
Description: Sum Formula: C46H73N13O10; CAS# [37827-06-8]

(Sar1,Thr8)-Angiotensin II

H-1745.0025 25.0mg
EUR 273
Description: Sum Formula: C44H69N13O11; CAS# [53632-49-8]

(Sar1,Thr8)-Angiotensin II

H-1745.0100 100.0mg
EUR 756
Description: Sum Formula: C44H69N13O11; CAS# [53632-49-8]

Angiotensin II 5-valine

HY-P0108 50mg
EUR 153

[Sar1, Ile8]-Angiotensin II

HY-P1564 50mg
EUR 497

Angiotensin II (AngII) Antibody

20-abx175396
  • EUR 411.00
  • EUR 133.00
  • EUR 1135.00
  • EUR 551.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Anti-Angiotensin II Antibody

A1588-100
EUR 338

Anti-Angiotensin II Antibody

A1588-30T
EUR 146

[Asn1, Val5]-Angiotensin II

5-00053 4 x 5mg Ask for price

[Sar1, Ala8]-Angiotensin II

5-00294 24 x 5mg Ask for price

[Sar1, Gly8]-Angiotensin II

5-00295 24 x 5mg Ask for price

[Sar1, Thr8]-Angiotensin II

5-00297 24 x 5mg Ask for price

[Val5] Angiotensin II, human

5-00373 4 x 5mg Ask for price

Angiotensin II [Sar1 Ile8]

5-00691 24 x 5mg Ask for price

Synthetic Angiotensin II (AngII)

4-SPA005Mi01
  • EUR 350.88
  • EUR 197.00
  • EUR 1040.80
  • EUR 413.60
  • EUR 727.20
  • EUR 298.00
  • EUR 2452.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: Inquire
  • Buffer composition: PBS, pH 7.4.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 1046.2Da
  • Isoelectric Point: 6.7
Description: Recombinant Human, Mouse, Rat Angiotensin II expressed in: E.coli

[Sar1,Ala8]-Angiotensin II

SP-100367-25 25 mg
EUR 286

[Sar1,Gly8]-Angiotensin II

SP-100368-25 25 mg
EUR 286

[Sar1,Thr8]-Angiotensin II

SP-100369-25 25 mg
EUR 286

Mouse Angiotensin converting enzyme 1 (ACE-1) control peptide # 1

ACE11-P 100 ug
EUR 164

Human Angiotensin converting enzyme 1 (ACE-1) control peptide # 2

ACE12-P 100 ug
EUR 164

Mouse Angiotensin converting enzyme 2 (ACE-2) control peptide # 1

ACE21-P 100 ug
EUR 164

Human Angiotensin converting enzyme 2 (ACE-2) control peptide # 2

ACE22-P 100 ug
EUR 164

Angiotensin I Peptide

20-abx265095
  • EUR 439.00
  • EUR 495.00
  • EUR 718.00
  • EUR 1247.00
  • EUR 328.00
  • 10 mg
  • 20 mg
  • 25 mg
  • 50 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin III Peptide

20-abx265119
  • EUR 356.00
  • EUR 537.00
  • EUR 286.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin A Peptide

20-abx266011
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Rat Angiotensin II (Ang II) ELISA Kit

abx575126-96tests 96 tests
EUR 668
  • Shipped within 5-12 working days.

Mouse Angiotensin II (Ang II) ELISA Kit

abx575127-96tests 96 tests
EUR 786
  • Shipped within 5-12 working days.

Angiotensin II (Ang II) (Human) ELISA Kit

E4527-100
EUR 805

Human ANG II(Angiotensin II) ELISA Kit

EH2627 96T
EUR 524.1
  • Detection range: 31.25-2000 pg/ml
  • Alias: ANG II
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml

Rat ANG II (Angiotensin II) ELISA Kit

ER1637 96T
EUR 567.6
  • Detection range: 31.25-2000 pg/ml
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 18.75pg/ml

Rabbit ANG II(Angiotensin II) ELISA Kit

ERB0006 96T
EUR 567.6
  • Detection range: 31.25-2000 pg/ml
  • Alias: ANG II
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rabbit;Sensitivity: 18.75pg/ml

Mouse Angiotensin II (Ang II) ELISA Kit

20-abx153637
  • EUR 6642.00
  • EUR 3542.00
  • EUR 825.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Rabbit Angiotensin II (Ang II) ELISA Kit

20-abx155034
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Rat Angiotensin II (Ang II) ELISA Kit

20-abx155198
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Chicken Angiotensin II (Ang II) ELISA Kit

20-abx150002
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Cow Angiotensin II (Ang II) ELISA Kit

20-abx150070
  • EUR 7645.00
  • EUR 4074.00
  • EUR 942.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Horse Angiotensin II (Ang II) ELISA Kit

20-abx150439
  • EUR 7378.00
  • EUR 3933.00
  • EUR 911.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Human Angiotensin II (Ang II) ELISA Kit

20-abx150654
  • EUR 6642.00
  • EUR 3542.00
  • EUR 825.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Rat Angiotensin II (Ang II) ELISA Kit

20-abx052349
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Human Angiotensin II (ANG II) CLIA Kit

abx195117-96tests 96 tests
EUR 825
  • Shipped within 5-12 working days.

Rat Angiotensin II (ANG II) CLIA Kit

abx195118-96tests 96 tests
EUR 825
  • Shipped within 5-12 working days.

Pig Angiotensin II (Ang II) ELISA Kit

abx351003-96tests 96 tests
EUR 754
  • Shipped within 5-12 working days.

Monkey Angiotensin II (Ang II) ELISA Kit

abx353381-96tests 96 tests
EUR 754
  • Shipped within 5-12 working days.

Sheep Angiotensin II (Ang II) ELISA Kit

abx364613-96tests 96 tests
EUR 926
  • Shipped within 5-12 working days.

Dog Angiotensin II (Ang II) ELISA Kit

abx355496-96tests 96 tests
EUR 926
  • Shipped within 5-12 working days.

Angiotensin II/III (Ang II/III) Antibody

abx411118-02mg 0.2 mg
EUR 565
  • Shipped within 1 week.

Rabbit Angiotensin II (Ang II) ELISA Kit

abx256971-96tests 96 tests
EUR 786
  • Shipped within 5-12 working days.

Human Angiotensin II (Ang II) ELISA Kit

20-abx252005
  • EUR 355.00
  • EUR 668.00
  • 24 tests
  • 96 tests
  • Shipped within 5-12 working days.

Chicken Angiotensin II (Ang II) ELISA Kit

abx250027-96tests 96 tests
EUR 754
  • Shipped within 5-12 working days.

General Ang-II/ Angiotensin II ELISA Kit

E0086Ge 1 Kit
EUR 563

Porcine angiotensin II (ANG II) ELISA Kit -

QY-E40071 96T
EUR 400

Mouse NOS-II/i-NOS Control/blocking peptide # 1

iNOS-P 100 ug
EUR 164

Mouse i-NOS/NOS-II Control/blocking peptide # 2

iNOS22-P 100 ug
EUR 164

human Topoisomerase II alpha (TOP2 alpha) Control/blocking peptide

TOP2A11-P 100 ug
EUR 164

(NANP)5 peptide (repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide

NANP51-P 1 mg
EUR 347

(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) control/blocking peptide

PPPP321-P 100 ug
EUR 164

Human Angiotensin II, pure (bioactive)

AT65-P-5 5 mg
EUR 286

Angiotensin I/II (5-8)

H-3846.0025 25.0mg
EUR 176
Description: Sum Formula: C26H36N6O5; CAS# [34233-50-6]

Angiotensin I/II (5-8)

H-3846.0100 100.0mg
EUR 466
Description: Sum Formula: C26H36N6O5; CAS# [34233-50-6]

(Sar1,Ile4·8)-Angiotensin II

H-6252.0005 5.0mg
EUR 273
Description: Sum Formula: C43H75N13O9; CAS# [185461-45-4] net

(Sar1,Ile4·8)-Angiotensin II

H-6252.0025 25.0mg
EUR 998
Description: Sum Formula: C43H75N13O9; CAS# [185461-45-4] net

Angiotensin I/II (3-7)

H-6965.0025 25.0mg
EUR 576
Description: Sum Formula: C31H45N7O7; CAS# [122483-84-5]

Angiotensin I/II (3-7)

H-6965.0100 100.0mg
EUR 1663
Description: Sum Formula: C31H45N7O7; CAS# [122483-84-5]

([ring-D5]Phe8)-Angiotensin II

H-7256.0001 1.0mg
EUR 113
Description: Sum Formula: C50H66D5N13O12; CAS# [1926163-73-6]

([ring-D5]Phe8)-Angiotensin II

H-7256.0005 5.0mg
EUR 360
Description: Sum Formula: C50H66D5N13O12; CAS# [1926163-73-6]

([ring-D5]Phe8)-Angiotensin II

H-7256.0025 25.0mg
EUR 1346
Description: Sum Formula: C50H66D5N13O12; CAS# [1926163-73-6]

Angiotensin I/II (3-8)

H-8125.0025 25.0mg
EUR 212
Description: Sum Formula: C40H54N8O8; CAS# [23025-68-5]

Angiotensin I/II (3-8)

H-8125.0100 100.0mg
EUR 576
Description: Sum Formula: C40H54N8O8; CAS# [23025-68-5]

(p-Amino-Phe6)-Angiotensin II

H-1022.0005 5.0mg
EUR 334
Description: Sum Formula: C53H74N12O12; CAS# [90937-05-6]

(p-Amino-Phe6)-Angiotensin II

H-1022.0025 25.0mg
EUR 1240
Description: Sum Formula: C53H74N12O12; CAS# [90937-05-6]

(Sar1,Val5,Ala8)-Angiotensin II

H-1232.0025 25.0mg
EUR 273
Description: Sum Formula: C42H65N13O10; CAS# [34273-10-4] net

(Sar1,Val5,Ala8)-Angiotensin II

H-1232.0100 100.0mg
EUR 756
Description: Sum Formula: C42H65N13O10; CAS# [34273-10-4] net

Angiotensin I/II (1-7)

H-1715.0025 25.0mg
EUR 321
Description: Sum Formula: C41H62N12O11; CAS# [51833-78-4] net

Angiotensin I/II (1-7)

H-1715.0100 100.0mg
EUR 902
Description: Sum Formula: C41H62N12O11; CAS# [51833-78-4] net

Angiotensin I/II (1-5)

H-2878.0025 25.0mg
EUR 357
Description: Sum Formula: C30H48N8O9; CAS# [58442-64-1]

Angiotensin I/II (1-5)

H-2878.0100 100.0mg
EUR 1009
Description: Sum Formula: C30H48N8O9; CAS# [58442-64-1]

Angiotensin I/II (1-6)

H-2882.0025 25.0mg
EUR 357
Description: Sum Formula: C36H55N11O10; CAS# [47896-63-9]

Angiotensin I/II (1-6)

H-2882.0100 100.0mg
EUR 1009
Description: Sum Formula: C36H55N11O10; CAS# [47896-63-9]

Angiotensin I/II (4-8)

H-2884.0025 25.0mg
EUR 176
Description: Sum Formula: C35H45N7O7; CAS# [52530-60-6]

Angiotensin I/II (4-8)

H-2884.0100 100.0mg
EUR 466
Description: Sum Formula: C35H45N7O7; CAS# [52530-60-6]
The cohort included 311 members from October 2015 to December 2016 at Paris Diderot and Paris Descartes University. At follow-up, there was a JSE-S whole rating improve of 1.22(SD:9.10) in the intervention group, in comparison with a lower of 1.64(SD:10.74) in the different group. Baseline JSE-S was positively related to Extraversion and Conscientiousness and negatively with Neuroticism. In distinction, we discovered no associations between baseline character traits and JSE-S change. There had been no interactions between character traits and randomization group.

Networking and Applying to Radiation Oncology During A Pandemic: Cross-Sectional Survey of Medical Student Concerns

We assessed the effectiveness of a digital networking session tailor-made for third- and fourth-year medical college students fascinated about radiation oncology, and report college students’ considerations about making use of to radiation oncology in the course of the pandemic. A multi-institutional networking session was hosted on Zoom and included medical college students, college, and residents from throughout the nation. The breakout room characteristic was used to divide members into smaller teams. Participants had been randomly shuffled into new teams each 10 to 15 minutes. Students accomplished pre- and post-session surveys.

Among the 134 college students who registered, 69 college students participated within the session, and 53 college students accomplished a post-session survey. Most college students reported the session was worthwhile or very worthwhile (79%), and it was straightforward or very straightforward to community via the digital format (66%). After the session, 18 (33.9%) college students reported their curiosity in radiation oncology elevated, and 34 (64.2%) reported their curiosity remained the identical. Most college students believed COVID-19 (55%) and digital interviews and platforms (55%) negatively or considerably negatively affected their means to choose a residency program. Most college students (62%) had been involved they are going to be inaccurately evaluated as an interviewee on a digital platform.

Although 30% agreed or strongly agreed the cost-savings and comfort of digital interviews outweigh potential downsides, 66% of college students had been planning to go to cities of curiosity in particular person earlier than rank checklist submission. Medical college students reported vital considerations with their means to be precisely evaluated and to select amongst residency applications on a digital platform. Students discovered the networking session to be a worthwhile useful resource for many college students, and applications might proceed related efforts in the course of the residency utility cycle to higher signify their program whereas sustaining sure monetary and geographic benefits of a digital surroundings.

Undergraduate nursing applications are required to put together nursing college students to take care of individuals throughout the lifespan, nevertheless due to restricted paediatric nursing content material in undergraduate nursing curricula and restricted paediatric medical placements, nursing graduates could lack competence and expertise in caring for youngsters.

Fireside Chats: A Novel Wellness Initiative for Medical Students within the COVID-19 Era

To complement preexisting wellness programming for the surgical procedure clerkship, a school surgeon at Vanderbilt initiated Fireside Chats (FC) in 2015. Inspired by Franklin Roosevelt’s Depression-era radio broadcasts, FC options small group sizes, off-campus excursions, and a reimagining of the mentor-mentee relationship that eschews hierarchy in favor of deep, mutualistic connections in each private and skilled domains. As conclusion, the general public narrative framework has modified the best way medical college students take into consideration how to mobilize individuals for well being promotion in a college.

Here we describe the rationale and implementation of FC and current survey knowledge that show the nice and cozy reception of FC and its efficacy in stewarding the psychological well being of medical college students. Moreover, not like giant group actions resembling “studying communities,” FC continues to meet in-person throughout COVID-19 and preserves social engagement alternatives that will alleviate pandemic-induced isolation and misery. Narrative approaches are gaining energy as sources of motivation to help the adoption of wholesome behaviors.

A qualitative, inductive content material evaluation was carried out to discover a trainer’s reflections on the experiences of a crew of medical college students utilizing public narratives to promote well being inside a Colombian college. Data had been collected from the trainer’s written reflective journal and an educational report, the latter, submitted by the medical college students. ‘Being mobilized’ emerged as an overarching class. The experiences had been described in three interrelated classes: crew involvement, boundaries and countering these boundaries. In phrases of crew involvement, college students had been motivated, dedicated, related with individuals and pissed off. On the opposite hand, boundaries resembling doubts and discomfort remarked, and lastly these boundaries had been countered via coaching, observe and teamwork.

Networking and Applying to Radiation Oncology During A Pandemic: Cross-Sectional Survey of Medical Student Concerns

The function of emotional competencies in predicting medical college students‘ attitudes in direction of communication abilities coaching

This research goals to examine whether or not stress, melancholy and emotional competencies will help to predict medical college students’ attitudes in direction of communication abilities coaching (CST). Anxiety and damaging attitudes in direction of CST have been proven to be linked. Conversely, emotional competencies (EC) had been related to constructive attitudes. Exploring these psycho(patho)logical variables subsequently appears to be a promising strategy to higher understanding, and even modifying, attitudes in direction of CST.
179 third yr medical college students had been requested to full the Communication Skills Attitude Scale (CSAS), the Perceived Stress Scale (PSS), the Montgomery-Asberg Depression Rating Scale Self-assessment (MADRS-S) and the Profile of Emotional Competence (PEC).  168 college students accomplished your entire questionnaire. The stepwise regression mannequin first revealed that, taken collectively, intrapersonal EC “Utilization” and interpersonal EC “Expression” account for 17% of the variance in constructive attitudes. Secondly, taken collectively, intrapersonal EC “Utilization” and interpersonal EC “Expression” account for 16% of the variance in damaging attitudes.
Compstatin control peptide
B5478-1 1 mg
EUR 373
Neuropeptide Y (scrambled)
B7530-1 1 mg
EUR 405
Description: Scrambled Neuropeptide Y (scNPY) was similarly synthesized and contains the same amino acids as NPY, but scNPY is in a random sequence, it was used as a control in the research in NPY [1]. The sequence of scNPY is SKPQRDANREPTRYAIYDYSNPDIELHYLRPAYALG-NH2 [2].
LL-37 scrambled peptide
HY-P1513 1mg
EUR 349
Scrambled TRAP Fragment Peptide
20-abx265858
  • EUR 356.00
  • EUR 537.00
  • EUR 286.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.
Positive control tissue section for each antibody; Based on availability INQUIRE
Control-Slides Set of 5
EUR 176
Human, mouse, rat connexin 32 hemi-channel-scrambled peptide
Cx3212-PS-1 1 mg
EUR 263
Rac1 Inhibitor F56, control peptide
B5275-1 1 mg
EUR 399
Bax inhibitor peptide, negative control
A4462-1 1 mg
EUR 340
Description: Negative control peptide for the Bax inhibitor peptides V5 and P5 , which inhibit Bax translocation to mitochondria and Bax-mediated apoptosis in vitro.
Human NEP1-40 of Nogo-66 peptide, Scrambled peptide control for NEP140, >95% pure
NEP140-115 100 ug
EUR 286
Human NEP1-40 of Nogo-66 peptide Scrambled peptide control for NEP140 >95% pure
NEP140-115-1000 1000 ug
EUR 773
L201 pLVPTH2- tTR- KRAB- Cerulean- scrambled- shRNA- Control
PVT11122 2 ug
EUR 301
Human, mouse, rat connexin 32 hemi-channel-Scrambled peptide (GAP24 domain)
Cx2410-PS-1 1 mg
EUR 286
Human, mouse, rat connexin 43 hemi-channel-Scrambled peptide (GAP26 domain)
Cx2606-PS-1 1 mg
EUR 286
Human, mouse, rat connexin 43 and 37 scrambled peptide (GAP27 domain)
Cx2704-PS-1 1 mg
EUR 263
Human, mouse, rat connexin 40 hemi-channel-Scrambled peptide (GAP27 domain)
Cx2708-PS-1 1 mg
EUR 263
3-D Life Scrambled RGD Peptide
09-P-003 1 µmol
EUR 121
3-D Life Scrambled RGD Peptide
P11-3 3x 1 µmol
EUR 276
Mouse Lipin-1 Control/blocking peptide control/blocking peptide #1
LPN11-P 100 ug
EUR 164
Human, mouse, rat connexin 37/40 hemi-channel Scrambled peptide (GAP26 domain)
Cx2602-PS-1 1 mg
EUR 286
Scrambled 10Panx
A2701-10 10 mg
EUR 258
Description: Scrambled 10Panx is the scrambled form of 10Panx (WRQAAFVDSY), a mimetic peptide of pannexin 1 that inhibits dye uptake by macrophages without affecting cellular membrane currents.
Scrambled 10Panx
A2701-25 25 mg
EUR 514
Description: Scrambled 10Panx is the scrambled form of 10Panx (WRQAAFVDSY), a mimetic peptide of pannexin 1 that inhibits dye uptake by macrophages without affecting cellular membrane currents.
Scrambled 10Panx
A2701-5 5 mg
EUR 166
Description: Scrambled 10Panx is the scrambled form of 10Panx (WRQAAFVDSY), a mimetic peptide of pannexin 1 that inhibits dye uptake by macrophages without affecting cellular membrane currents.
Mouse Lipin-2 Control/blocking peptide control/blocking peptide #1
LPN21-P 100 ug
EUR 164
Mouse Lipin-3 Control/blocking peptide control/blocking peptide #1
LPN31-P 100 ug
EUR 164
TRAF6 Control Peptide
H-7606.0001 1.0mg
EUR 506
Description: Sum Formula: C139H232N34O42; CAS# [852690-80-3] net
LL-37 (scrambled)
H-7886.0500 0.5mg
EUR 283
Description: Sum Formula: C205H340N60O53; CAS# [1354065-56-7] net
LL-37 (scrambled)
H-7886.1000 1.0mg
EUR 441
Description: Sum Formula: C205H340N60O53; CAS# [1354065-56-7] net
Scrambled TRAP Fragment
5-01910 4 x 5mg Ask for price
Donkey IgG (Control, non-immune, isotype control)
20028-1 1 mg
EUR 164
AH1 peptide (gp70 H2-Ld-restricted epitope) (SPSYVYHQF, >95%) Control/blocking peptide
AH11-P-1 1 mg
EUR 225
Flg15 peptide (deletion peptide 30-44 aa, Flic, P. aeruginosa) control,pure
FLG15-P-1 1 mg
EUR 286
Mouse Peptide YY (PYY) control/blocking peptide # 1
PYY11-P 100 ug
EUR 164
Mouse control serum, CD-1
NMOS-CD1-1 1 ml
EUR 103
Human Aven Control/blocking peptide # 1
AVEN11-P 100 ug
EUR 164
Drosophila BMAL Control/blocking peptide # 1
BMALD11-P 100 ug
EUR 164
Rat EAAT4 Control/blocking peptide #1
EAAT41-P 100 ug
EUR 164
Human EAAT5 Control/blocking peptide #1
EAAT51-P 100 ug
EUR 164
Mouse GPR39 control antigen peptide #1
GPR391-P 100 ug
EUR 164
Human HE2 Control/blocking peptide #1
HE21-P 100 ug
EUR 164
Human Ghrelin control/blocking peptide # 1
GHS11-P 100 ug
EUR 164
Human Galanin Control/blocking peptide # 1
GAL51-P 100 ug
EUR 164
Human CYP26A1 control/blocking peptide #1
CYP26A11-P 100 ug
EUR 164
Mouse Clock Control/blocking peptide # 1
CLO11-P 100 ug
EUR 164
Drosophila Clock Control/blocking peptide # 1
CLO13-P 100 ug
EUR 164
Human MutY Control/blocking peptide #1
MUTY11-P 100 ug
EUR 164
Human NHERF1 Control/blocking peptide #1
NHERF11-P 100 ug
EUR 164
Human NHERF2 Control/blocking peptide #1
NHERF21-P 100 ug
EUR 164
Human Nicastrin control (blocking) peptide #1
NICN11-P 100 ug
EUR 164
Rat Nephrin Control/blocking peptide #1
NPHN11-P 100 ug
EUR 164
Mouse Leptin Control/blocking peptide # 1
OB11-P 100 ug
EUR 164
Human KST1 Control/blocking peptide # 1
KST11-P 100 ug
EUR 164
Mouse Per1 Control/blocking peptide #1
PER11-P 100 ug
EUR 164
Drosophila Per1 Control/blocking peptide # 1
PER14-P 100 ug
EUR 164
Mouse Per2 Control/blocking peptide #1
PER21-P 100 ug
EUR 164
Mouse Per3 Control/blocking peptide #1
PER31-P 100 ug
EUR 164
Human Podocin Control/blocking peptide #1
PODO11-P 100 ug
EUR 164
Human Podocalyxin Control/blocking peptide #1
PODX11-P 100 ug
EUR 164
Human MOP3 Control/blocking peptide #1
MOP31-P 100 ug
EUR 152
Human MOP4 Control/blocking peptide #1
MOP41-P 100 ug
EUR 164
Human Motilin control/blocking peptide # 1
MOTL11-P 100 ug
EUR 164
Rat UT2 Control/blocking peptide #1
RUT21-P 100 ug
EUR 164
Rat Syntenin Control/blocking peptide #1
SDB11-P 100 ug
EUR 164
Human Tankyrase Control/blocking peptide #1
TANK11-P 100 ug
EUR 164
Rat VGLUT1/BNPI control peptide # 1
VGLUT11-P 100 ug
EUR 164
Human VGLUT2/DNPI control peptide # 1
VGLUT21-P 100 ug
EUR 164
Human APOBEC 1 Control/blocking peptide # 1
APOBEC11-P 100 ug
EUR 164
Human Merlin 1 Control/blocking peptide #1
MERL11-P 100 ug
EUR 164
JAG - 1 (188 - 204), Jagged – 1 (188 - 204), Notch Ligand
5-01413 4 x 1mg Ask for price
Amyloid b-Protein (1-42) (scrambled)
H-7406.0500 0.5mg
EUR 441
Description: Sum Formula: C203H311N55O60S; CAS# [1678415-52-5] net
Amyloid b-Protein (1-42) (scrambled)
H-7406.1000 1.0mg
EUR 589
Description: Sum Formula: C203H311N55O60S; CAS# [1678415-52-5] net
Amyloid b-Protein (1-40) (scrambled)
H-7408.0500 0.5mg
EUR 335
Description: Sum Formula: C194H295N53O58S; CAS# [1678415-68-3] net
Amyloid b-Protein (1-40) (scrambled)
H-7408.1000 1.0mg
EUR 606
Description: Sum Formula: C194H295N53O58S; CAS# [1678415-68-3] net
Control Magnetic Beads
M1302-1
EUR 98
Human, mouse, rat connexin 32 hemi-channel-scrambled peptide
Cx3212-PS-5 5 mg
EUR 773
Rat neurofascin (Nfasc)-control Control/blocking peptide
AB-23249-CP 100ug
EUR 164
Llama IgG (Control, non-immune, isotype control, ELISA grade)
20030-1 1 mg
EUR 164
Camel IgG (Control, non-immune, isotype control, ELISA grade)
20031-1 1 mg
EUR 164
Alpaca IgG (Control, non-immune, isotype control, ELISA grade)
20032-1 1 mg
EUR 164
Control/Blocking peptide CD40
CD4011-C 100 ug
EUR 164
Control/Blocking peptide EOMES
EMS11-C 100 ug
EUR 164
Kemptide Negative Control Peptide
20-abx265856
  • EUR 356.00
  • EUR 537.00
  • EUR 286.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.
Mouse VGLUT3 control peptide
VGLUT31-P 100 ug
EUR 164
Human VGLUT3 control peptide
VGLUT32-P 100 ug
EUR 164
Human Gastric inhibitory peptide (GIP) Control/blocking peptide #1
GIP71-P 100 ug
EUR 164
Human Peptide Histidine-Methionine (PHM) Control/blocking peptide #1
PHM11-P 100 ug
EUR 164
Mouse Vasoactive intestinal peptide (VIP) Control/blocking peptide #1
VIP16-P 100 ug
EUR 164
Rat Exchange inhibitory peptide (XIP) Control/blocking peptide #1
XIP11-P 100 ug
EUR 164
Scrambled sgRNA CRISPR Lentivector
K018 1.0 ug
EUR 154
Rat Aquaporin 1 (AQP1) Control/blocking peptide #1
AQP11-P 100 ug
EUR 164
Rat Aquaporin 1 (AQP1) Control/blocking peptide #1
AQP12-P 100 ug
EUR 164
Mouse Cryptochrome 1 (CRY1) Control/blocking peptide # 1
CRY11-P 100 ug
EUR 164
Mouse beta-Defensin 1 control/blocking peptide #1
MBD11-P 100 ug
EUR 164
QVD-OPh Negative Control
1171-1
EUR 207
Custom Neg Control siRNA
M1256-1
EUR 278
Labeled Neg Control siRNA
M1257-1
EUR 311
Custom Pos Control siRNA
M1258-1
EUR 278
miRNA Inhibitor Neg Control
M1266-1
EUR 278
Rat Akt-2 Control/blocking peptide #1
AKT21-P 100 ug
EUR 164
Rat Akt-3 Control/blocking peptide #1
AKT31-P 100 ug
EUR 164
Human Cachectic Factor Control/blocking peptide #1
CACH11-P 100 ug
EUR 164
Human Aquaporin AQPAP Control/blocking peptide # 1
AQPAP11-P 100 ug
EUR 164
Rat AVP V1a Control/blocking peptide # 1
AVP1A11-P 100 ug
EUR 164
Rat Bin 1b Control/blocking peptide #1
BIN1B11-P 100 ug
EUR 164
Beta catenin 1 (CTNNB1) Control/Blocking Peptide
BCTN11-C 100 ug
EUR 164
Rat EAAC1/EAAT3 Control/blocking peptide #1
EAAC11-P 100 ug